These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2500455)

  • 61. The RTX pore-forming toxin α-hemolysin of uropathogenic Escherichia coli: progress and perspectives.
    Wiles TJ; Mulvey MA
    Future Microbiol; 2013 Jan; 8(1):73-84. PubMed ID: 23252494
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Activation of type II alveolar epithelial cells during acute endotoxemia.
    Sunil VR; Connor AJ; Guo Y; Laskin JD; Laskin DL
    Am J Physiol Lung Cell Mol Physiol; 2002 Apr; 282(4):L872-80. PubMed ID: 11880315
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hyperpermeability of pulmonary endothelial monolayer: protective role of phosphodiesterase isoenzymes 3 and 4.
    Suttorp N; Ehreiser P; Hippenstiel S; Fuhrmann M; Krüll M; Tenor H; Schudt C
    Lung; 1996; 174(3):181-94. PubMed ID: 8830194
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vivo effects of intravascularly applied Escherichia coli hemolysin: dissociation between induction of granulocytopenia and lethality in monkeys.
    Vagts D; Dienes HP; Barth PJ; Ronneberger H; Hungerer KD; Bhakdi S
    Med Microbiol Immunol; 1993 Mar; 182(1):1-12. PubMed ID: 8497209
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cytocidal effects of Escherichia coli hemolysin on human T lymphocytes.
    Jonas D; Schultheis B; Klas C; Krammer PH; Bhakdi S
    Infect Immun; 1993 May; 61(5):1715-21. PubMed ID: 8478059
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pore-forming bacterial toxins potently induce release of nitric oxide in porcine endothelial cells.
    Suttorp N; Fuhrmann M; Tannert-Otto S; Grimminger F; Bhadki S
    J Exp Med; 1993 Jul; 178(1):337-41. PubMed ID: 8391061
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Endotoxin "priming" potentiates lung vascular abnormalities in response to Escherichia coli hemolysin: an example of synergism between endo- and exotoxin.
    Walmrath D; Ghofrani HA; Rosseau S; Schütte H; Cramer A; Kaddus W; Grimminger F; Bhakdi S; Seeger W
    J Exp Med; 1994 Oct; 180(4):1437-43. PubMed ID: 7931076
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Proteinaceous bacterial toxins and pathogenesis of sepsis syndrome and septic shock: the unknown connection.
    Bhakdi S; Grimminger F; Suttorp N; Walmrath D; Seeger W
    Med Microbiol Immunol; 1994 Jul; 183(3):119-44. PubMed ID: 7527897
    [No Abstract]   [Full Text] [Related]  

  • 69. Effects of Escherichia coli hemolysin on human monocytes. Cytocidal action and stimulation of interleukin 1 release.
    Bhakdi S; Muhly M; Korom S; Schmidt G
    J Clin Invest; 1990 Jun; 85(6):1746-53. PubMed ID: 2189890
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of Escherichia coli hemolysin on endothelial cell function.
    Suttorp N; Flöer B; Schnittler H; Seeger W; Bhakdi S
    Infect Immun; 1990 Nov; 58(11):3796-801. PubMed ID: 2121650
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inflammatory lipid mediator generation elicited by viable hemolysin-forming Escherichia coli in lung vasculature.
    Grimminger F; Thomas M; Obernitz R; Walmrath D; Bhakdi S; Seeger W
    J Exp Med; 1990 Oct; 172(4):1115-25. PubMed ID: 2120384
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Leukotriene and hydroxyeicosatetraenoic acid generation elicited by low doses of Escherichia coli hemolysin in rabbit lungs.
    Grimminger F; Walmrath D; Birkemeyer RG; Bhakdi S; Seeger W
    Infect Immun; 1990 Aug; 58(8):2659-63. PubMed ID: 2115026
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The different hemolysins of Escherichia coli.
    Beutin L
    Med Microbiol Immunol; 1991; 180(4):167-82. PubMed ID: 1784268
    [No Abstract]   [Full Text] [Related]  

  • 74. Escherichia coli hemolysin is a potent inductor of phosphoinositide hydrolysis and related metabolic responses in human neutrophils.
    Grimminger F; Sibelius U; Bhakdi S; Suttorp N; Seeger W
    J Clin Invest; 1991 Nov; 88(5):1531-9. PubMed ID: 1658043
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Superoxide generation by human neutrophils induced by low doses of Escherichia coli hemolysin.
    Bhakdi S; Martin E
    Infect Immun; 1991 Sep; 59(9):2955-62. PubMed ID: 1652556
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Thromboxane-mediated hypertension and vascular leakage evoked by low doses of Escherichia coli hemolysin in rabbit lungs.
    Seeger W; Walter H; Suttorp N; Muhly M; Bhakdi S
    J Clin Invest; 1989 Jul; 84(1):220-7. PubMed ID: 2500455
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lung vascular injury after administration of viable hemolysin-forming Escherichia coli in isolated rabbit lungs.
    Seeger W; Obernitz R; Thomas M; Walmrath D; Suttorn N; Holland IB; Grimminger F; Eberspächer B; Hugo F; Bhakdi S
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):797-805. PubMed ID: 1826193
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Induction of severe vascular leakage by low doses of Escherichia coli hemolysin in perfused rabbit lungs.
    Ermert L; Rousseau S; Schütte H; Birkemeyer RG; Grimminger F; Bhakdi S; Duncker HR; Seeger W
    Lab Invest; 1992 Mar; 66(3):362-9. PubMed ID: 1538589
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Staphylococcal alpha-toxin elicits hypertension in isolated rabbit lungs. Evidence for thromboxane formation and the role of extracellular calcium.
    Seeger W; Bauer M; Bhakdi S
    J Clin Invest; 1984 Sep; 74(3):849-58. PubMed ID: 6432850
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Escherichia coli hemolysin causes thromboxane-mediated hypertension and vascular leakage in rabbit lungs.
    Seeger W; Walter H; Neuhof H; Suttorp N; Bhakdi S
    Prog Clin Biol Res; 1989; 308():67-72. PubMed ID: 2675066
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.